Inconsistencies in Modeling the Efficacy of the Oncolytic Virus HSV1716 Reveal Potential Predictive Biomarkers for Tolerability
Treatment with HSV1716 via intralesional administration has proven successful for melanoma patients with the hope that oncolytic virotherapy would become another weapon in the systemic anticancer therapy (SACT) arsenal. In addition to challenges surrounding the systemic delivery of oncolytic viruses...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2022-06-01
|
| Seri Bilgileri: | Frontiers in Molecular Biosciences |
| Konular: | |
| Online Erişim: | https://www.frontiersin.org/articles/10.3389/fmolb.2022.889395/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|